Skip to content
Homepage
Free · Private · Treatment fit

Do I Need HRT? Quiz

Menopausal hormone therapy fits some situations very well, fits others poorly, and is unsafe in a few. This quiz sorts your answers into four groups, symptoms, timing, better-matched options and safety, so you know which conversation to have with a clinician. It is a fit quiz, not a prescription.

  • Fit quiz
  • About 4 min
  • Original items, informed by the NAMS 2022 position statement
  • Runs in your browser, nothing is sent
  • Medical review: Medical review pending

If your symptoms are severe or sudden, seek urgent medical care.

Start the test

Four groups, kept apart on purpose

Whether hormone therapy is a good fit depends on three separate things: what you are trying to treat, when you would be starting relative to menopause, and whether anything in your history makes it unsafe. Most online quizzes blend them into one score. This one keeps them apart, because each one changes the conversation differently.

  1. 1

    Symptoms hormone therapy treats best

    Hot flashes and night sweats, sleep broken by sweats, vaginal dryness and painful sex, and the bother these cause. These are the symptoms with the strongest evidence for benefit: the NAMS 2022 position statement calls hormone therapy the most effective treatment for vasomotor symptoms and the genitourinary syndrome of menopause.

  2. 2

    The timing window

    Age under 60, within ten years of the final period, or menopause that came early. The benefit-to-risk balance is most favorable in this window and less favorable when therapy is started later. Early menopause and surgical menopause strengthen the case rather than weaken it.

  3. 3

    Better-matched options and safety questions

    Some situations are better served by local vaginal estrogen or a non-hormonal medicine than by systemic hormones, and some histories, such as breast cancer, a blood clot or unexplained bleeding, need a specialist decision before anything else. One safety yes overrides the rest of the result.

How this compares with a typical online quiz

FeatureTypical free quizRegenerated.com
Separates symptoms from timing and safetyRarelyYes, four groups scored apart
Safety screen that overrides the resultNoYes, one safety yes comes first
Names the guideline it followsSometimesYes, the NAMS 2022 position statement
Explains the timing windowNoYes, with the figures behind it
Says when local estrogen or a non-hormonal option fits betterNoYes, as its own group
Email gate before the resultCommonNone
Answers sent to a serverOftenNever; scored in your browser, counts-only events

The timing window, explained

The large Women's Health Initiative trials of the early 2000s enrolled women whose average age was 63, many of them more than a decade past menopause, and reported more heart events, strokes and clots in the hormone group. Re-analysis by age showed something different: women who started therapy under 60 or within ten years of their final period had no excess of heart disease and, in some analyses, fewer heart events and lower mortality. Those who started later carried the extra risk. This is the timing hypothesis, and it is now built into every major guideline.

The NAMS 2022 position statement puts it plainly: for women under 60 or within ten years of menopause onset who have no contraindications, the benefit-to-risk ratio is favorable for treating bothersome hot flashes and night sweats and for preventing bone loss. For women starting more than ten years out or after 60, the ratio is less favorable because the absolute risks of coronary disease, stroke, clots and dementia rise. The window does not close like a door; it shifts the balance, and a clinician weighs it against how much the symptoms are costing you.

Early menopause changes the arithmetic

If your periods stopped before 45, or your ovaries were removed before the usual age of menopause, the calculation runs the other way. Years without estrogen before 51 are associated with higher risks of bone loss, heart disease and cognitive decline, and guidelines advise hormone therapy at least until the average age of natural menopause unless there is a specific reason not to. In primary ovarian insufficiency, before 40, the case is stronger still. The quiz scores these situations in the timing group because they are the clearest case for starting rather than waiting.

When a different conversation fits better

Vaginal dryness, discomfort during sex and recurrent urinary infections without hot flashes respond to low-dose vaginal estrogen, which is absorbed minimally and is appropriate for most women, including many for whom systemic therapy is not. Hot flashes in a woman who cannot or would rather not take hormones can be treated with fezolinetant, a non-hormonal neurokinin receptor antagonist approved in 2023, or with certain antidepressants, gabapentin or oxybutynin. Weight gain, low energy, memory lapses and a drop in desire are real and common in this period, but systemic hormone therapy is not reliably a treatment for them on their own, and a clinician will usually look for the actual cause first.

Methodology and sources

The quiz is informed by the 2022 hormone therapy position statement of The North American Menopause Society and by the Stages of Reproductive Aging Workshop criteria for timing. Every item is original. The symptom group asks about concrete events in the past month rather than rating symptom severity on a scale; the timing group records age, years since the final period and early or surgical menopause; the better-matched group covers situations the statement assigns to local estrogen, non-hormonal medicines or a different diagnosis; the safety group lists the contraindications the statement names: current or past breast cancer or other estrogen-sensitive cancer, a previous venous clot, stroke or heart attack, unexplained vaginal bleeding, active liver disease, a known clotting disorder; and, as a condition to bring under control before any prescription rather than a contraindication, untreated high blood pressure.

The quiz scores each group as the share of its questions you answered yes to, and the group with the largest share leads the result. A single yes in the safety group replaces the leading group, because none of the other answers matter until a clinician has addressed that history. The result is educational. It tells you which conversation to have and what to bring to it. It does not say whether you should take hormone therapy, which preparation, at what dose or by which route; those are decisions a clinician makes with your full history, examination and, where useful, blood tests and a mammogram.

Medical review: Medical review pending. Last updated .

References

  1. The 2022 Hormone Therapy Position Statement of The North American Menopause Society Advisory Panel. The 2022 hormone therapy position statement of The North American Menopause Society. Menopause. 2022;29(7):767-794. doi:10.1097/GME.0000000000002028
  2. Manson JE, Chlebowski RT, Stefanick ML, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. JAMA. 2013;310(13):1353-1368. doi:10.1001/jama.2013.278040
  3. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. J Clin Endocrinol Metab. 2012;97(4):1159-1168. doi:10.1210/jc.2011-3362
  4. The 2020 Genitourinary Syndrome of Menopause Position Statement of The North American Menopause Society. Menopause. 2020;27(9):976-992. doi:10.1097/GME.0000000000001609

Do I Need HRT? Quiz FAQ

No. It can sort your situation into the groups that matter, symptoms, timing, better-matched options and safety, so you walk into an appointment knowing what to ask. Whether hormone therapy is right for you, and in what form, is a decision made with a clinician who knows your history.

Starting hormone therapy under 60 or within ten years of your final period carries a favorable balance of benefit and risk for bothersome symptoms. Starting later carries higher absolute risks of heart disease, stroke and clots. The window shifts the balance; it does not forbid treatment, and a clinician weighs it against your symptoms.

Usually not. Low-dose vaginal estrogen treats dryness, painful sex and recurrent urinary infections with minimal absorption into the bloodstream, and it is appropriate for most women, including many who should not take systemic therapy. That is why the quiz scores it in a separate group.

A history of breast cancer or another estrogen-sensitive cancer, a previous blood clot in the leg or lung, a stroke or heart attack, unexplained vaginal bleeding, active liver disease, and a known clotting disorder. Untreated high blood pressure sits in the same group on this quiz, though the position statement treats it as something to bring under control before any prescription rather than as a contraindication. Each one needs a clinician's decision before any prescription, and the quiz puts that conversation first.

Menopause before 45, or ovary removal before the usual age, strengthens the case for hormone therapy rather than weakening it. Guidelines advise treatment at least until the average age of natural menopause, around 51, unless there is a specific reason not to. Raise it directly with a clinician.

Yes. Your answers and the numbers you enter are scored in your browser and are never sent to us. They stay in this browser tab so you can return to your result, and closing the tab clears them. The only thing the page sends us is a counts-only event: which test was started or completed, the result band and the headline number, with no answers, no entered values and no account. There is nothing to sign up for.

Find clinics offering menopausal hormone therapy

Browse US clinics that provide hormone replacement therapy. Look for physician oversight on the profile, a full history and blood pressure check before prescribing, the non-hormonal options discussed too, and a review within three months of starting. A listing is not an endorsement.

Browse HRT clinics

A listing is not a treatment endorsement. Read each clinic's published checks and talk to your clinician before starting any treatment.

Important: This quiz is an educational sorting tool, not a medical assessment, not a diagnosis of menopause or any condition, and not a recommendation for or against hormone therapy. The decision to prescribe, and what to prescribe, belongs to a clinician who knows your full history. If your symptoms are severe or sudden, seek urgent medical care.